Please try another search
Cellnovo Group SA, a medical technology company, develops and markets mobile diabetes management systems. The company’s mobile diabetes management system includes insulin pump and activity monitor, as well as cellular-enabled wireless touchscreen handset with automatic connectivity to secure servers. Its system allows optimal management of insulin injections, as well as the patient’s condition to be monitored by family members and healthcare professionals in real time. The company markets its systems through direct sales force in the United Kingdom and France, as well as through distributors internationally. Cellnovo Group SA has a partnership with Diabeloop SA for the development of an artificial pancreas solution. The company was incorporated in 2014 and is based in Paris, France.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review